Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, Eric C. Klawiter, A. Jacob et al.|Research Padua Archive (University of Padua)|2020Cited by 139
Retinal Optical Coherence Tomography in Neuromyelitis OpticaFrederike Cosima Oertel, Ibis Soto de Castillo, Lekha Pandit et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 84
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Jacqueline Palace, Brian G. Weinshenker et al.|Journal of Neurology|2015Cited by 65
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Bruno Stankoff, Anne‐Laure Dubessy et al.|Multiple Sclerosis Journal|2022Cited by 46